Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Carroll

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
European Urology Open Science|January 13, 2022
Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) ConsortiumJonathan Olivier, Weiyu Li, Daan Nieboer, et al.
European Urology|October 11, 2016
Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task ForceSilvia Villa, Friederike Kendel, Lionne Venderbos, et al.
Prostate International|July 9, 2015
Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer managementHideyuki Akaza, Choung Soo Kim, Peter Carroll, et al.
Urology|July 25, 2016
An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary CareE David Crawford, Matt T Rosenberg, Alan W Partin, et al.
The American Journal of Pathology|February 25, 2003
High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarraysPamela L Paris, Donna G Albertson, Janneke C Alers, et al.
Urology Practice|May 5, 2023
Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Lisa Newcomb, et al.
Research Square|May 25, 2026
Defining the combinatorial nature of gene modules in prostate cancer underlying lineage plasticity and metastasisFranklin Huang, Hanbing Song, Junxiang Xu, et al.
The Journal of Urology|December 2, 2021
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Kehao Zhu, et al.
European Urology Open Science|July 11, 2022
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 InitiativeSebastiaan Remmers, Jozien Helleman, Daan Nieboer, et al.
European Urology|June 29, 2016
Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task ForceCaroline M Moore, Francesco Giganti, Peter Albertsen, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
European Urology Open Science|January 13, 2022
Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) ConsortiumJonathan Olivier, Weiyu Li, Daan Nieboer, et al.
European Urology|October 11, 2016
Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task ForceSilvia Villa, Friederike Kendel, Lionne Venderbos, et al.
Prostate International|July 9, 2015
Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer managementHideyuki Akaza, Choung Soo Kim, Peter Carroll, et al.
Urology|July 25, 2016
An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary CareE David Crawford, Matt T Rosenberg, Alan W Partin, et al.
The American Journal of Pathology|February 25, 2003
High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarraysPamela L Paris, Donna G Albertson, Janneke C Alers, et al.
Urology Practice|May 5, 2023
Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Lisa Newcomb, et al.
Research Square|May 25, 2026
Defining the combinatorial nature of gene modules in prostate cancer underlying lineage plasticity and metastasisFranklin Huang, Hanbing Song, Junxiang Xu, et al.
The Journal of Urology|December 2, 2021
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Kehao Zhu, et al.
European Urology Open Science|July 11, 2022
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 InitiativeSebastiaan Remmers, Jozien Helleman, Daan Nieboer, et al.
European Urology|June 29, 2016
Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task ForceCaroline M Moore, Francesco Giganti, Peter Albertsen, et al.
Pageof 8